332 related articles for article (PubMed ID: 17828306)
1. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
You JS; Kang JK; Lee EK; Lee JC; Lee SH; Jeon YJ; Koh DH; Ahn SH; Seo DW; Lee HY; Cho EJ; Han JW
Oncogene; 2008 Feb; 27(10):1376-86. PubMed ID: 17828306
[TBL] [Abstract][Full Text] [Related]
2. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
3. PKCepsilon is essential for gelsolin expression by histone deacetylase inhibitor apicidin in human cervix cancer cells.
Eun DW; Ahn SH; You JS; Park JW; Lee EK; Lee HN; Kang GM; Lee JC; Choi WS; Seo DW; Han JW
Biochem Biophys Res Commun; 2007 Mar; 354(3):769-75. PubMed ID: 17257588
[TBL] [Abstract][Full Text] [Related]
4. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Im JY; Kim J; Choi WS; Kim HS
Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
[TBL] [Abstract][Full Text] [Related]
5. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
6. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
Ueda T; Takai N; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
8. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
[TBL] [Abstract][Full Text] [Related]
9. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
Han JW; Ahn SH; Park SH; Wang SY; Bae GU; Seo DW; Kwon HK; Hong S; Lee HY; Lee YW; Lee HW
Cancer Res; 2000 Nov; 60(21):6068-74. PubMed ID: 11085529
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of p21(WAF1/CIP1) by apicidin, a novel histone deacetylase inhibitor.
Kim JS; Lee S; Lee T; Lee YW; Trepel JB
Biochem Biophys Res Commun; 2001 Mar; 281(4):866-71. PubMed ID: 11237739
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites.
Kim S; Kang JK; Kim YK; Seo DW; Ahn SH; Lee JC; Lee CH; You JS; Cho EJ; Lee HW; Han JW
Biochem Biophys Res Commun; 2006 Apr; 342(4):1168-73. PubMed ID: 16516150
[TBL] [Abstract][Full Text] [Related]
12. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
Kim YH; Lim JH; Lee TJ; Park JW; Kwon TK
J Cell Biochem; 2007 Jul; 101(4):987-95. PubMed ID: 17407153
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of human gamma-globin transcriptional induction by apicidin involves p38 signaling to chromatin.
Wei GH; Zhao GW; Song W; Hao DL; Lv X; Liu DP; Liang CC
Biochem Biophys Res Commun; 2007 Nov; 363(4):889-94. PubMed ID: 17910885
[TBL] [Abstract][Full Text] [Related]
15. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116.
Choi JH; Min NY; Park J; Kim JH; Park SH; Ko YJ; Kang Y; Moon YJ; Rhee S; Ham SW; Park AJ; Lee KH
Biochem Biophys Res Commun; 2010 Jan; 391(1):449-54. PubMed ID: 19914212
[TBL] [Abstract][Full Text] [Related]
16. Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis.
Kim YK; Lee EK; Kang JK; Kim JA; You JS; Park JH; Seo DW; Hwang JW; Kim SN; Lee HY; Lee HW; Han JW
Cell Death Differ; 2006 Dec; 13(12):2033-41. PubMed ID: 16628233
[TBL] [Abstract][Full Text] [Related]
17. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4.
Ahn MY; Chung HY; Choi WS; Lee BM; Yoon S; Kim HS
Int J Oncol; 2010 Jan; 36(1):125-31. PubMed ID: 19956841
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
